Plus Therapeutics (PSTV) Institutional Ownership $0.31 -0.03 (-7.72%) Closing price 04:00 PM EasternExtended Trading$0.31 0.00 (0.00%) As of 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Plus Therapeutics (NASDAQ:PSTV)CurrentInstitutional OwnershipPercentage3.28%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$873.99KNumber ofInstitutional Sellers(last 12 months)0 Get PSTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Plus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PSTV Institutional Buying and Selling by Quarter Plus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/12/2025 Virtu Financial LLC40,030$38K0.0%N/A0.235% 8/7/2024 AIGH Capital Management LLC568,681$836K0.3%N/A9.977% 11/15/2022 Parkman Healthcare Partners LLC1,325,025$590K0.2%-13.6%3.943% 8/8/2022 Otter Creek Advisors LLC330,168$178K0.1%+293.5%1.465% 5/13/2022 Parkman Healthcare Partners LLC1,526,316$1.53M0.4%N/A6.875% 5/9/2022 Otter Creek Advisors LLC83,901$84K0.0%N/A0.378% 11/9/2021BlackRock Inc.128,323$245K0.0%-19.7%0.835% 9/17/2021 Virtu Financial LLC76,187$195K0.0%N/A0.630% 8/16/2021 State Street Corp34,214$88K0.0%N/A0.283% 8/13/2021 Renaissance Technologies LLC17,607$45K0.0%N/A0.146% 8/13/2021 Northern Trust Corp40,524$104K0.0%N/A0.335% 8/13/2021 Geode Capital Management LLC130,793$334K0.0%N/A1.082% 8/13/2021 Vanguard Group Inc.712,847$1.83M0.0%+824.7%5.897% 8/12/2021 Dimensional Fund Advisors LP68,430$175K0.0%N/A0.566% 8/11/2021 Susquehanna Fundamental Investments LLC13,033$33K0.0%N/A0.108% (Data available from 1/1/2016 forward) PSTV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PSTV shares? During the previous two years, the following institutional investors and hedge funds held shares of Plus Therapeutics shares: AIGH Capital Management LLC ($836K), Virtu Financial LLC ($38K).Learn more on PSTV's institutional investors. What percentage of Plus Therapeutics stock is owned by institutional investors? 3.28% of Plus Therapeutics stock is owned by institutional investors. Learn more on PSTV's institutional investor holdings. Which institutional investors have been buying Plus Therapeutics stock? The following institutional investors have purchased Plus Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($568.68K), and Virtu Financial LLC ($40.03K). How much institutional buying is happening at Plus Therapeutics? Institutional investors have bought a total of 608,711 shares in the last 24 months. This purchase volume represents approximately $873.99K in transactions. Related Companies Apyx Medical Institutional Ownership Modular Medical Institutional Ownership TELA Bio Institutional Ownership Envoy Medical Institutional Ownership Baird Medical Investment Institutional Ownership Daxor Institutional Ownership Precision Optics Institutional Ownership electroCore Institutional Ownership Spectral AI Institutional Ownership DarioHealth Institutional Ownership This page (NASDAQ:PSTV) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.